New clinical trials surrounding this compound, specifically the high-dose formulation ZPHC ZPHC, reveal a significant impact on physique reduction and related metabolic conditions . Experts posit that this combined acting , influencing both GLP-1 and GIP systems, has the potential to represent a noteworthy breakthrough in the approach of obesity a